Using telemedicine to improve glaucoma screening and care in underserved communities
DP24-081 Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine (MI-SIGHT) Program: A Pragmatic Randomized Trial
This study is looking to improve glaucoma care for people in underserved communities by using telemedicine, where eye doctors can check eye health data collected by local technicians, making it easier for those at higher risk, especially in minority and low-income groups, to get the help they need.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11025059 on NIH RePORTER |
What this research studies
This research aims to enhance glaucoma screening and treatment for underserved populations by utilizing telemedicine. It focuses on Federally Qualified Health Centers (FQHCs) where eye doctors will use advanced technology to review ophthalmic data collected by local technicians. This approach allows for better identification and management of glaucoma in high-risk communities, particularly among minority and low-income individuals. The study will evaluate the effectiveness and cost-effectiveness of these telemedicine protocols in improving patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from minority backgrounds or those with lower incomes who are at higher risk for glaucoma.
Not a fit: Patients who do not have access to Federally Qualified Health Centers or those who are not at risk for glaucoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and better management of glaucoma, significantly reducing visual impairment in high-risk populations.
How similar studies have performed: Previous research has shown that telemedicine can effectively improve screening rates for glaucoma and other eye diseases in underserved communities.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Newman-Casey, Paula Anne — University of Michigan at Ann Arbor
- Study coordinator: Newman-Casey, Paula Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.